# Trading Analysis — 2026-10-28

## Portfolio Overview

| Metric | Value |
|--------|-------|
| Total Value | €9,796.88 |
| Cash | €2,505.79 (25.58%) |
| Positions | €7,291.09 |
| Total Return | **-2.03%** |
| Daily Change | -€18.64 (-0.19%) |
| Benchmark (EW) | €9,765.11 (-2.35%) |
| **Gap vs Benchmark** | **+0.32 pp** |
| Sharpe Ratio | -0.96 |
| Volatility | 5.19% |
| Max Drawdown | -1.91% |

## Daily Decision

**Regime:** Volatility normal (50th percentile), trend neutral, correlation normal.

**LLM Decision:** All 10 positions held. No trades executed.

**Reasoning:** Cash at ~25.6% is comfortably within the 15–30% target band for the normal volatility regime, so no forced deployment is required. DBA is approaching the -5% stop-loss threshold but the documented override policy remains active (RSI deeply oversold, Bollinger position extreme). The LLM maintained the hard exit threshold at -7% total drawdown.

## Position Highlights

| Ticker | Weight | P&L % | Note |
|--------|--------|-------|------|
| SPY | 20.91% | +3.44% | Largest position, healthy gains |
| TLT | 13.49% | +1.32% | Bond ETF stabilizer |
| REET | 9.37% | -0.38% | Slight pullback |
| ^FCHI | 7.57% | +0.68% | CAC 40 index |
| AI.PA | 5.26% | +1.83% | Air Liquide |
| DBA | 4.63% | **-4.74%** | Oversold, override active |
| MC.PA | 4.52% | +0.13% | Monday's buy, flat |
| IJR | 4.16% | +0.52% | Small-cap ETF |
| PDBC | 2.61% | +13.01% | Best performer |
| SAN.PA | 1.89% | +3.33% | Sanofi |

## Risk Metrics

- **CVaR 95%:** +0.75%
- **VaR 95%:** +0.63%
- **Max Drawdown:** -1.91% (strategy low)
- **Volatility:** 5.19% (up from 5.31% — slight decrease)

## H4 Shadow Arm

Record #7: All-hold, matching live arm. Buy-target agreement streak remains paused at n=5.

## Observations

- The DBA override policy is being stress-tested in real time. The position is now at -4.74% (entry) and the -7% hard threshold is ~2.26 pp of additional decline away. The mean-reversion thesis is intact but not confirmed.
- Portfolio underperformed the benchmark slightly today (-0.19% vs benchmark's implicit move), but the cumulative gap remains positive at +0.32 pp.
- Cash mid-band means no forced buying or selling pressure. The LLM is preserving optionality.
- No confirming sell signals on TLT/AI.PA despite elevated RSI readings from prior sessions.

---

*Almost surely, patience converges.* 🦀

## Research Session Notes (2026-10-28 22:30 UTC)

Analysis suite re-run post-daily-pipeline (all 6 artifacts current for 2026-10-28):

- **Decision analyzer:** 5D win rate 40.0% < 45% threshold — banner reads "LLM underperforming" (qualified window). Risk-adjusted returns marginal.
- **Behavioral analysis:** win rate 28.6%, avg hold 51.1 days. Long holds (>14d) win 40.0% vs short holds (≤3d) 0.0% — the edge, if any, lives in patience. Ledger reconciliation clean: booked €-20.36 vs replayed €-20.36 (gap €+0.00).
- **Cash-alpha correlation:** Pearson +0.008, Spearman +0.075 over the standing window — confirms "cash drag is a level effect, not a daily signal." n logged; no re-investigation per standing rule (monthly deep re-run on the ~6th).
- **Cash drag report:** 63 drag days vs 19 cap-binding days — the weekly cap binds less often than prompt conservatism.
- **Keyword trends:** "let winners run" rising (+0.68), "deflated sharpe" falling (-2.04).
- **Alpha vs SPY B&H:** -15.62 pp since 2026-02-17 (strategy -2.03% vs SPY +13.59%) — the daily benchmark gap (+0.32 pp) is recent noise on a long underperformance.

### DBA override watch (day 2)
- Unrealized -4.73% vs entry; hard threshold -7% ⇒ price €26.47, ~2.4% further decline from €27.11.
- LLM reasoning re-confirms the mean-reversion thesis: RSI 8.7, Bollinger position -0.14.

### Shadow arm
Record #7 all-hold matches live arm exactly (10/10 tickers). No divergence.

---
